Get started
Author

Julien Parola

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux
2015 · Sandy Giuliano, Yann Cormerais, et al. · Autophagy · 141
PDF
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2017 · Maeva Dufies, Sandy Giuliano, et al. · Cancer Research · 105
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
2019 · Maeva Dufies, Oleksandr Grytsai, et al. · Theranostics · 57
PDF
Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5
2019 · Sandy Giuliano, Maeva Dufies, et al. · Theranostics · 45
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy
2021 · Anais Hagege, Damien Ambrosetti, et al. · Theranostics · 42
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
2021 · Maeva Dufies, Annelies Verbiest, et al. · Communications Biology · 41
PDF
Cabozantinib, a Promising Therapeutic Strategy for Resistant Head and Neck Squamous Cell Carcinoma Patients
2021 · Anais Hagege, Esma Saada-Bouzid, et al. · Cell Reports Medicine · 38
PDF
Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients
2020 · Lucilla Fabbri, Maeva Dufies, et al. · Theranostics · 33
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
2017 · Maeva Dufies, Sandy Giuliano, et al. · British Journal of Cancer · 30
PDF
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma
2018 · Maeva Dufies, Marie Nollet, et al. · Theranostics · 22
PDF
De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
2025 · Manon Teisseire, Umakant Sahu, et al. · Cancer Research · 10
Co‐culture of human fibroblasts, smooth muscle and endothelial cells promotes osteopontin induction in hypoxia
2020 · Nirvana Sadaghianloo, Julie Contenti, et al. · Journal of Cellular and Molecular Medicine · 9
PDF
ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines
2017 · Maeva Dufies, Damien Ambrosetti, et al. · Oncotarget · 7
PDF
Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancer
2026 · Manon Teisseire, Arthur Karaulic, et al. · Theranostics · 1
PDF
Supplementary Data from De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
2025 · Manon Teisseire, Umakant Sahu, et al. · 1
Resistance to sunitinib in clear cell renal cell carcinoma results from drug sequestration in lysosomes and inhibition of autophagic flux
2016 · S. Giuliano, Y. Cormerais, et al. · European Journal of Cancer · 1
Table 1 from De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
2025 · Manon Teisseire, Umakant Sahu, et al.
Data from De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
2025 · Manon Teisseire, Umakant Sahu, et al.
Supplementary Data from De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
2025 · Manon Teisseire (21364995), Umakant Sahu (21364998), et al. · Figshare
Table 1 from De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
2025 · Manon Teisseire (21364995), Umakant Sahu (21364998), et al. · Figshare
Supplementary Figure Legends from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2023 · Maeva Dufies, Sandy Giuliano, et al.
Supplemental Figure S7 from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2023 · Maeva Dufies, Sandy Giuliano, et al.
Supplemental Figure S2 from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2023 · Maeva Dufies, Sandy Giuliano, et al.
Supplemental Table S1 from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2023 · Maeva Dufies, Sandy Giuliano, et al.
Supplemental Figure S1 from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
2023 · Maeva Dufies, Sandy Giuliano, et al.
Works count: 34
Citation count: 583
H-index: 10
I10-index: 11
Year
Topic
Type